Seaport Therapeutics, Inc. (SPTX)

Seaport Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Seaport Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.05	-0.05	-0.20
Debt / EBITDA Ratio	-0.06	-0.06	-0.10
Debt / FCF Ratio	-0.06	-0.06	-0.17
Net Debt / Equity Ratio	2.28	2.28	12.24
Net Debt / EBITDA Ratio	2.41	2.41	5.83
Net Debt / FCF Ratio	2.69	2.69	10.22
Quick Ratio	16.90	16.90	27.72
Return on Equity (ROE)	80.91%	80.91%	188.66%
Return on Assets (ROA)	-30.07%	-30.07%	-14.85%
Return on Capital Employed (ROCE)	-36.20%	-36.20%	-17.21%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).